Editas Medicine
EDIT
215 hedge funds and large institutions have $1.15B invested in Editas Medicine in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 56 reducing their positions, and 25 closing their positions.
84% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 25
49% more call options, than puts
Call options by funds: $40.4M | Put options by funds: $27.1M
30% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 56
11% more capital invested
Capital invested by funds: $1.03B → $1.15B (+$119M)
9% more funds holding
Funds holding: 197 → 215 (+18)
1.62% more ownership
Funds ownership: 66.44% → 68.05% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$20.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.2M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$19.9M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.14M |
| 5 |
Morgan Stanley
New York
|
+$6.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$40.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$12.1M |
| 3 |
Millennium Management
New York
|
-$10.3M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$7.37M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$6.39M |
EDIT Hedge Fund Activity: Q2 2018 in Review
215 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2018, worth a combined $1.15B — up 11% from $1.03B a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new EDIT positions and 25 closed out — a net gain of 21 holders — while 73 added to existing stakes and 56 trimmed.
The largest buyer was BlackRock, adding an estimated $20.9M. The largest seller was Fidelity Investments, cutting an estimated $40.7M.
- 215 institutional investors held Editas Medicine (EDIT) as of Q2 2018, up from 197 in Q1 2018.
- Funds reported $1.15B of Editas Medicine stock for Q2 2018, up 11% quarter-over-quarter.
- 46 funds opened new Editas Medicine positions in Q2 2018 and 25 closed out, a net change of +21 holders.
- The largest Editas Medicine buyer in Q2 2018 was BlackRock, an estimated $20.9M added.
- The largest Editas Medicine seller in Q2 2018 was Fidelity Investments, an estimated $40.7M sold.
Based on aggregated 13F filings for Q2 2018.